Home » Topics » BioWorld Science

BioWorld Science
RSS

Suzhou Kintor Pharmaceuticals studies lead c-Myc/MAX protein-protein interaction inhibitor

July 7, 2020

EXOSC4 gene is tied to breast cancer progression and poor survival

July 7, 2020

Clinical study of desidustat for the management of COVID-19 approved in Mexico

July 7, 2020

FDA lifts partial clinical hold on pivotal phase II study of camidanlumab tesirine

July 7, 2020

Researchers identify claudin 18.2-targeting antibodies

July 7, 2020

AdAlta moves AD-214 into the clinic

July 7, 2020

Sunshine Lake Pharma presents CD19-targeting antibodies

July 7, 2020

Japanese researchers report new immunosuppressants

July 7, 2020

SIAT patents anti-H7N9 fully human monoclonal antibody 2G3 for H7N9 viral infection

July 7, 2020

OncoSec Medical divulges expression vectors encoding nucleic acid sequences for cancer

July 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...